Ambrx Biopharma Total Assets 2020-2021 | AMAM

Ambrx Biopharma total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ambrx Biopharma Annual Total Assets
(Millions of US $)
2020 $134
2019 $62
Ambrx Biopharma Quarterly Total Assets
(Millions of US $)
2020-12-31 $134
2019-12-31 $62
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.188B $0.014B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88